NIKA PHARMACEUTICALS, INC. Deferred Income Tax Expense (Benefit)
NIKA PHARMACEUTICALS, INC. (NIKA) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2022-03-03
- NIKA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2021 was $0.00.
- NIKA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 |